Nipro Corporation (FRA:5FA)
Germany
· Delayed Price · Currency is EUR 7.80
-0.10 (-1.27%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Medical Related | 505.08B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medical Related Growth | 11.35% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Association | 79.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Association Growth | 6.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharma Packaging | 59.26B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharma Packaging Growth | 2.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 1.12B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 37.13% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2005 - 2019 |
| Japan | 314.47B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Japan Growth | 3.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| America | 130.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| America Growth | 20.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 107.33B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | 10.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 92.63B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 19.99% |
Log In |
Log In |
Log In |
Log In | Upgrade
|